Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 4/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL3327760 | 0.98 | ALDH1A1 (0.39) | ALDH1A1TSHRLMNASMN1; SMN2ALOX12 | |
| SCHEMBL4373436 | 0.91 | ALDH1A1 (0.40) | ALDH1A1TSHRLMNASMN1; SMN2ALOX12 | |
| SCHEMBL4369368 | 0.83 | ALDH1A1 (0.40) | ALDH1A1TSHRLMNASMN1; SMN2ALOX12 | |
| SCHEMBL5196982 | 0.74 | TRPA1 (0.43) | ALDH1A1TSHRLMNASMN1; SMN2HPGD | |
| SCHEMBL150091 | 0.73 | TSHR (0.41) | ALDH1A1TSHRLMNASMN1; SMN2ALOX12 | |
| SCHEMBL10848388 | 0.69 | ALDH1A1 (0.50) | ALDH1A1TSHRLMNASMN1; SMN2ALOX12 | |
| SCHEMBL752673 | 0.68 | TSHR (0.41) | ALDH1A1TSHRSMN1; SMN2ALOX12HPGD | |
| SCHEMBL112040 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL31150435 | 0.67 | TSHR (0.39) | ALDH1A1TSHRSMN1; SMN2ALOX12HPGD | |
| Hydrochloric Acid SCHEMBL154108 | 0.67 | TSHR (0.39) | ALDH1A1TSHRSMN1; SMN2ALOX12HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078142-A1 | FULLY-CONTINUOUS SYNTHESIS METHOD OF CYPROTERONE ACETATE | UNIV FUDAN (CN) | 2026-03-19 | — | — | US | claimed |
| CN-102596967-B | Prepare the photochemical method of Artemisinin | SAI NUOFEI (FR) | 2015-08-26 | — | — | CN | claimed |
| EP-2046767-B1 | PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS | PROVENCE TECHNOLOGIES (FR) | 2015-04-22 | — | — | EP | claimed |
| US-8765942-B2 | Process for preparing diaminophenothiazinium compounds | PROVENCE TECHNOLOGIES (FR) | 2014-07-01 | — | — | US | claimed |
| US-20130299338-A1 | PHOTOCHEMICAL PROCESS FOR PRODUCING ARTEMISININ | SANOFI SA (FR) | 2013-11-14 | — | — | US | claimed |
| US-8507697-B2 | Photochemical process for producing artemisinin | SANOFI (FR) | 2013-08-13 | — | — | US | claimed |
| EP-2473512-A1 | PHOTOCHEMICAL PROCESS FOR PRODUCING ARTEMISININ | SANOFI (FR) | 2012-07-11 | — | — | EP | claimed |
| US-20110250296-A1 | REVERSE VITAMIN K EFFECT VIA PHOTODYNAMIC OXIDATION TARGETED AT VASCULAR ENDOTHELIUM, FIBRIN AND BLOOD PLATELETS | WINSLOW DAVID E | 2011-10-13 | — | — | US | claimed |
| US-7968127-B2 | Reverse vitamin K effect via photodynamic oxidation targeted at vascular endothelium, fibrin and blood platelets | WINSLOW DAVID E | 2011-06-28 | — | — | US | claimed |
| US-20100021566-A1 | REVERSE VITAMIN K EFFECT VIA PHOTODYNAMIC OXIDATION TARGETED AT VASCULAR ENDOTHELIUM, FIBRIN AND BLOOD PLATELETS | WINSLOW DAVID E | 2010-01-28 | — | — | US | claimed |
| US-20090291943-A1 | PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS | PROVEPHARM LIFE SOLUTIONS (FR) | 2009-11-26 | — | — | US | claimed |
| EP-4017496-B1 | FORMULATIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF PERIPHERAL NEUROPATHY AND ITS ASSOCIATED DISEASES | LOH YIN SZE (SG) | 2026-01-07 | — | — | EP | disclosed |
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2025-10-23 | — | — | US | disclosed |
| US-20250222006-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LTD. (SG) | 2025-07-10 | — | — | US | disclosed |
| EP-3795565-B1 | IMPROVED PROCESS FOR THE PURIFICATION OF METHYLENE BLUE | RK PHARMA INC (US) | 2025-07-09 | — | — | EP | disclosed |
| US-6022549-A | NONAQUEOUS, COMPRISING A PHENOL ANTIMICROBIAL AGENT, A FILM FORMING RESIN, AND ORGANIC SOLVENT; THE PHENOL IS STORAGE STABLE AND CAPABLE OF LEACHING FOLLOWING SOLIDIFICATION OF THE NAIL COATING WITHOUT LOSING MICROBIOCIDAL ACTIVITY | WOODWARD LABORATORIES, INC. (US) | 2000-02-08 | — | — | US | disclosed |
| US-6013677-A | APPLYING TO THE NAIL A NON-AQUEOUS ANTIMICROBIAL NAIL COATING CONTAINING A FILM FORMING POLYMER, AN ORGANIC SOLVENT, A ANTIMICROBIAL AGENT COMPRISING SOLUBILZED BENZALKONIUM CHLORIDE AND CAPABLE OF LEACHING FROM NAIL COATING | WOODWARD LABORATORIES, INC. (US) | 2000-01-11 | — | — | US | disclosed |
| US-5968986-A | NONAQUEOUS NAIL COATING WITH MICROBIOCDES AND POLYMERS | WOODWARD LABORATORIES, INC. (US) | 1999-10-19 | — | — | US | disclosed |
| US-5961469-A | Spectrophotometric assay for cyanide | ROIZEN MICHAEL F (US) | 1999-10-05 | — | — | US | disclosed |
| WO-1999036033-A1 | ANTIMICROBIAL NAIL COATING COMPOSITION | WOODWARD LABORATORIES, INC. (US) | 1999-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | ALDH1A1 2648/4885TSHR 1453/4885LMNA 222/4885 |
| US-20250222006-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | MB, TPMT, HBB | ALDH1A1 1477/4885TSHR 1603/4885LMNA 2166/4885 |
| US-20100021566-A1 | REVERSE VITAMIN K EFFECT VIA PHOTODYNAMIC OXIDATION TARGETED AT VASCULAR ENDOTHELIUM, FIBRIN AND BLOOD PLATELETS | PROC, PFKP, TTPA | ALDH1A1 2051/4885TSHR 3001/4885LMNA 2440/4885 |
| US-20110250296-A1 | REVERSE VITAMIN K EFFECT VIA PHOTODYNAMIC OXIDATION TARGETED AT VASCULAR ENDOTHELIUM, FIBRIN AND BLOOD PLATELETS | PROC, PFKP, TTPA | ALDH1A1 2051/4885TSHR 3001/4885LMNA 2440/4885 |
| US-20130299338-A1 | PHOTOCHEMICAL PROCESS FOR PRODUCING ARTEMISININ | DHPS, FDPS, GGPS1 | ALDH1A1 559/4885TSHR 4498/4885LMNA 2799/4885 |
| US-20090291943-A1 | PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS | DCPS, QDPR, DNPEP | ALDH1A1 1379/4885TSHR 3603/4885LMNA 2709/4885 |
| US-20260078142-A1 | FULLY-CONTINUOUS SYNTHESIS METHOD OF CYPROTERONE ACETATE | CYP17A1, CYP21A2, HSD17B2 | ALDH1A1 241/4885TSHR 456/4885LMNA 2995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.